Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans

Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin

(2016) Jeffrey N. Higaki et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

The Val142Ile transthyretin cardiac amyloidosis

(2016) Francesco Cappelli et al.   Journal of Cardiovascular Medicine

Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging

(2016) Adam Castano et al.   JAMA Cardiology

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa

(2016) Daniel R. Jacobson et al.   Molecular Genetics & Genomic Medicine

Tafamidis in Transthyretin Amyloid Cardiomyopathy: Effects on Transthyretin Stabilization and Clinical Outcomes

(2015) M. S. Maurer et al.   Circulation-Heart Failure

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

(2015) Thibaud Damy et al.   EUROPEAN HEART JOURNAL

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

(2015) Duncan B. Richards et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans

(2015) C. Cristina Quarta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver Transplantation for Hereditary Transthyretin Amyloidosis

(2015) Bo-Göran Ericzon et al.   TRANSPLANTATION

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

(2015) John L. Berk et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Silencing of murine transthyretin and retinol binding protein genes has distinct and shared behavioral and neuropathologic effects

(2014) J.N. Buxbaum et al.   NEUROSCIENCE

99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

(2013) Sabahat Bokhari et al.   Circulation-Cardiovascular Imaging

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

(2013) Teresa Coelho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis

(2013) Theodoros D. Karamitsos et al.   JACC-Cardiovascular Imaging

Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis

(2013) Giampaolo Merlini et al.   Journal of Cardiovascular Translational Research

The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients

(2012) Jason Dungu et al.   AMERICAN HEART JOURNAL

Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)

(2012) Frederick L. Ruberg et al.   AMERICAN HEART JOURNAL

Delayed development of specific thyroid hormone-regulated events in transthyretin null mice

(2012) Julie A. Monk et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

(2012) Laura Obici et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy

(2012) Elizabeth J. Ackermann et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy

(2012) Laerke M. Nelson et al.   CLINICAL TRANSPLANTATION

The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug

(2012) Steven M. Johnson et al.   JOURNAL OF MOLECULAR BIOLOGY

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice Models

(2012) Nelson Ferreira et al.   PLoS One

Relation of Clinical, Echocardiographic and Electrocardiographic Features of Cardiac Amyloidosis to the Presence of the Transthyretin V122I Allele in Older African-American Men

(2011) Daniel Jacobson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Highly Refractile Myocardial Echoes in Familial Amyloidosis with Polyneuropathy: A Correlative Echocardiographic and Histopathological Study

(2010) PETER ERIKSSON et al.   ACTA MEDICA SCANDINAVICA

Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis

(2009) Lawreen H. Connors et al.   AMERICAN HEART JOURNAL

Comparison of Magnetic Resonance Imaging Versus Doppler Echocardiography for the Evaluation of Left Ventricular Diastolic Function in Patients With Cardiac Amyloidosis

(2009) Ronen Rubinshtein et al.   AMERICAN JOURNAL OF CARDIOLOGY

Systemic Cardiac Amyloidoses

(2009) Claudio Rapezzi et al.   CIRCULATION

Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac Amyloidosis

(2008) I. M. Hamour et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Transthyretin is not expressed by dorsal root ganglia cells

(2008) Mónica Mendes Sousa et al.   EXPERIMENTAL NEUROLOGY

Usefulness of 99mTc-DPD Scintigraphy in Cardiac Amyloidosis

(2008) Claudio Rapezzi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY